Zusammenfassung
Die meisten Buchkapitel und Reviewartikel über die Ejaculatio praecox (EP) beginnen mit der Feststellung, dass die EP mit einer Prävalenz von bis zu 30 % die am häufigsten auftretende sexuelle Funktionsstörung des Mannes sei. Wäre das so, wäre die uns schon hinlänglich bekannte Diskrepanz zwischen der Vorkommenshäufigkeit sexueller Dysfunktionen und der viel geringeren Inanspruchnahmerate professioneller Hilfe bei dieser sexuellen Funktionsstörung besonders groß, da nach allen verfügbaren Daten und klinischen Erfahrungen die Anzahl der Männer, die wegen einer EP Hilfe sucht, deutlich geringer ist als der entsprechende Prozentsatz bei Erektionsstörungen – einer Dysfunktion, deren Prävalenz z. B. in der NHSLS-Studie deutlich niedriger ist (vgl. Abschn. 13.3 und 14.4). Sowohl diese ausgeprägte Diskrepanz als auch die hohen Prävalenzzahlen der EP relativieren sich allerdings deutlich, wenn man berücksichtigt, dass es sich bei den meisten Studienergebnissen (auch bei der NHSLS) um eine reine Selbsteinschätzung der Befragten gehandelt hat, die nicht auf den gültigen EP-Störungskriterien oder gar einer soliden klinischen Diagnostik beruhte. Wie wir noch sehen werden, sind diese Störungskriterien in den aktuellen Definitionen der EP durch die Einführung eindeutiger Grenzwerte für die Ejakulationslatenzzeit (1 min bei lebenslanger, 3 min bei erworbener EP) inzwischen präzisiert worden. In den Untersuchungen, in denen allein die Ejakulationslatenzzeit mit diesen Grenzwerten als Störungskriterium vorgegeben wurde, reduzierte sich die Prävalenz der EP auf lediglich 1–3 % (Jannini und Lenzi 2005; Waldinger et al. 2009) und wäre demnach also dramatisch niedriger. Nimmt man zur Ejakulationslatenzzeit (IELT = intravaginal ejaculatory latency time) aber das klinisch bedeutsamere Kriterium der mangelnden Kontrolle über den Ejakulationszeitpunkt sowie den subjektiven Leidensdruck hinzu, dürfte sich die „wahre“ Prävalenz der EP wohl zwischen 5–15 % bewegen, wobei ethnische, regionale und altersbedingte Unterschiede als Einflussfaktoren fungieren (s. dazu Abschn. 14.3 und 14.4). Die EP ist somit auch mit diesen korrigierten Zahlen immer noch eine häufige sexuelle Funktionsstörung des Mannes.
Mit Fallbeispielen von Uwe Hartmann
Literatur
Abdel-Hamid, I. A., Andersson, K.-E., Waldinger, M. D., & Anis, T. H. (2016). Tramadol abuse and sexual function. Sexual Medicine Reviews, 4, 235–246.
Althof, S. E. (2014). Treatment of premature ejaculation: Psychotherapy, pharmacotherapy, and combined therapy. In Y. M. Binik & K. S. Hall (Hrsg.), Principles and practice of sex therapy (5. Aufl.). Guilford: New York.
Althof, S. E., Abdo, C. H. N., Dean, J., Hackett, G., McCabe, M., McMahon, C. G., … Tan, H. M. (2010). International Society for Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation. The Journal of Sexual Medicine, 7, 2947–2969.
Althof, S. E., McMahon, C. G., Waldinger, M. D., Serefoglu, E. C., Shindel, A. W., Adaikan, P. G., & Hellstrom, W. J. (2014). An update of the International Society of Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation (PE). The Journal of Sexual Medicine, 11(6), 1392–1422.
Arentewicz, G., & Schmidt, G. (1980). Sexuell gestörte Beziehungen: Konzept und Technik der Paartherapie (1. Aufl.). Berlin: Springer.
Arentewicz, G., & Schmidt, G. (1993). Sexuell gestörte Beziehungen. Konzept und Technik der Paartherapie (3. Aufl.). Stuttgart: Enke.
Barlow, D. H. (1986). Causes of sexual dysfunction: The role of anxiety and cognitive Interference. Journal of Consulting and Clinical Psychology, 54(2), 140–148.
Beck, J. G., & Barlow, D. H. (1984). Current conceptualizations of sexual dysfunction: A review and an alternative perspective. Clinical Psychology Review, 4(4), 363–378.
Becker, N. (1980). Psychoanalytische Ansätze bei der Therapie sexueller Funktionsstörungen (2. Aufl.). In: V. Sigusch (Hrsg.), Therapie sexueller Störungen. Stuttgart: Thieme.
Beier, K. M., Bosinski, H. A. G., Hartmann, U., & Loewit, K. (2001). Sexualmedizin. München: Urban & Fischer.
Buddeberg, C., Bass, B., & Gnirss-Bormet, R. (1994). Die lustlose Frau – der impotente Mann. Familiendynamik, 19(3), 266–280.
Burri, A., Giuliano, F., McMahon, C., & Porst, H. (2014). Female partner’s perception of premature ejaculation and its impact on relationship breakups, relationship quality, and sexual satisfaction. The Journal of Sexual Medicine, 11(9), 2243–2255.
Buvat, J. (2011). Pathophysiology of premature ejaculation. The Journal of Sexual Medicine, 8(4), 316–327.
Carson, C., & Wyllie, M. (2010). Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: Results of a phase III, double‐blind, placebo‐controlled study. The Journal of Sexual Medicine, 7(9), 3179–3189.
Catalan, J., Hawton, K., & Day, A. (1990). Couples referred to a sexual dysfunction clinic. Psychological and physical morbidity. The British Journal of Psychiatry, 156(1), 61–67.
De Amicis, L. A., Goldberg, D. C., LoPiccolo, J., Friedman, J., & Davies, L. (1985). Clinical follow-up of couples treated for sexual dysfunction. Arch Sex Behav Archives of Sexual Behavior: The Official Publication of the International Academy of Sex Research, 14(6), 467–489.
De Carufel, F. (2009). L’éjaculation prématurée: compréhension et traitement par la thérapie sexofonctionnelle:. de Louvain: Presses univ.
De Carufel, F. (2016). Premature ejaculation: Therapy, evaluation and therapeutic treatment. New York: Routledge.
De Carufel, F., & Trudel, G. (2006). Effects of a new functional-sexological treatment for premature ejaculation. Journal of Sex & Marital Therapy, 32(2), 97–114.
Desjardins, J.-Y. (1986). L’approche sexo-corporelle (fondements théoriques et champs d’application). Psychothérapies, 6(1), 51–58.
Dinsmore, W. W., & Wyllie, M. G. (2009). PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: Results of a phase III, multicentre, double‐blind, placebo‐controlled study. BJU International, 103(7), 940–949.
Donatucci, C. F. (2006). Etiology of ejaculation and pathophysiology of premature ejaculation. The Journal of Sexual Medicine, 3(4), 303–308.
Dresser, M., Desai, D., Gidwani, S., Seftel, A., & Modi, N. (2006). Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors. International Journal of Impotence Research, 18(1), 104–110.
Eaton, H. (1973). Clomipramine (Anafranil) in the treatment of premature ejaculation. Journal of International Medical Research, 1(5), 432–434.
El-Nashaar, A., & Shamloul, R. (2007). Antibiotic treatment can delay ejaculation in patients with premature ejaculation and chronic bacterial prostatitis. The Journal of Sexual Medicine, 4(2), 491–496.
Gallo, L., Perdonà, S., & Gallo, A. (2010). The role of short frenulum and the effects of frenulectomy on premature ejaculation. European Urology, 7, 1269–1276.
Giuliano, F. (2011). Neurophysiology of erection and ejaculation. The Journal of Sexual Medicine, 8(4), 310–315.
Gokce, A., & Halis, F. (2013). Childhood enuresis is associated with shorter intravaginal ejaculatory latency time in healthy men. The Journal of Urology, 189(6), 2223–2228.
Goodman, R. (1980). An assessment of clomipramine (Anafranil) in the treatment of premature ejaculation. The Journal of International Medical Research, 8, 53–59.
Hartmann, U. (1996). The „PEQUEST“: A multidimensional instrument for the assessment of premature ejaculation. International Journal of Impotence Research, 8, 119.
Hartmann, U., & Neuhof, C. (2015). Sexuelle Störungen. In W. Domschke, M. Berger, W. Hohenberger, T. Meinertz, & K. Possinger (Hrsg.), Therapie-Handbuch (5. Aufl.). München: Urban & Fischer.
Hartmann, U., & Uhlemann, H. (1995). Phänomenologische und psychophysiologische Merkmale der Ejaculatio praecox: Ergebnisse einer empirischen Vergleichsstudie. Sexuologie, 3, 131–147.
Hartmann, U., Schedlowski, M., & Krüger, T. (2005). Cognitive and partner-related factors in rapid ejaculation: Differences between dysfunctional and functional men. World Journal of Urology, 23(2), 93–101.
Hartmann, U., Becker, A. J., Ückert, S., & Stief, C. G. (2006). Neurobiologie sexueller Funktionsstörungen. In H. Förstl, M. Hautzinger, & G. Roth (Hrsg.), Neurobiologie psychischer Störungen (pp. 763–806). Heidelberg: Springer.
Hatzimouratidis, K., Eardley, I., Giuliano, F., Hatzichristou, D., Moncada, I., & Salonia, A. (2015). Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. European Association of Urology 2015. http://www.uroweb.org. Zugegriffen: 06.Okt. 2016.
Hawton, K., & Catalan, J. (1986). Prognostic factors in sex therapy. Behaviour Research and Therapy, 24(4), 377–385.
Hawton, K., Catalan, J., Martin, P., & Fagg, J. (1986). Long-term outcome of sex therapy. Behaviour Research and Therapy, 24(6), 665–675.
Heiman, J. R., & Lopiccolo, J. (1983). Clinical outcome of sex therapy. Effects of daily vs weekly treatment. Archives of General Psychiatry, 40(4), 443.
Jannini, E. A., & Lenzi, A. (2005). Epidemiology of premature ejaculation. Current Opinion in Urology, 15(6), 399–403.
Jannini, E. A., Maggi, M., and Lenzi, A. (2011). Evaluation of premature ejaculation.The Journal of Sexual Medicine,8(Suppl. 4), 328–334.
Janssen, P. K., Bakker, S. C., Réthelyi, J., Zwinderman, A. H., Touw, D. J., Olivier, B., & Waldinger, M. D. (2009). Serotonin transporter promoter region (5-HTTLPR) polymorphism is associated with the intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation. The Journal of Sexual Medicine, 6(1), 276–284.
Jern, P., Santtila, P., Witting, K., Alanko, K., Harlaar, N., Johansson, A., & Ålgars, M. (2007). Premature and delayed ejaculation: Genetic and environmental effects in a population‐based sample of Finnish twins. The Journal of Sexual Medicine, 4(6), 1739–1749.
Kaplan, H. S. (1974). The new sex therapy: Active treatment of sexual dysfunctions. Oxford: Brunner/Mazel.
Koyuncu, H., Serefoglu, E. C., Karacay, S., Ozdemir, A. T., Kalkan, M., & Yencilek, F. (2014). Is there a correlation between intravaginal ejaculatory latency time and enuresis? An exploratory study. Central European Journal of Urology, 67(1), 74–78.
Laumann, E. O., Gagnon, J. H., Michael, R. T., & Michaels, S. (1994). The social organization of sexuality: Sexual practices in the United States. London: University of Chicago.
Laumann, E. O., Paik, A., & Rosen, R. C. (1999). Sexual dysfunction in the United States: Prevalence and predictors. Jama, 281(6), 537–544.
Laumann, E. O., Nicolosi, A., Glasser, D. B., Paik, A., Gingell, C., Moreira, E., & Wang, T. (2005). Sexual problems among women and men aged 40–80 y: Prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. International Journal of Impotence Research, 17(1), 39–57.
Levine, S. B. (1992). Helping men to control ejaculation sexual life (S. 90–106). Ort ergänzen: Springer.
Masters, W. H., & Johnson, V. E. (1966). Human sexual response. Boston: Little, Brown.
Masters, W. H., & Johnson, V. E. (1970). Human sexual inadequacy (1st Aufl.). Boston: Little, Brown.
McCabe, M. P., Althof, S. E., Assalian, P., Chevret-Measson, M., Leiblum, S. R., Simonelli, C., & Wylie, K. (2010). Psychological and interpersonal dimensions of sexual function and dysfunction. The Journal of Sexual Medicine, 7(1pt2), 327–336.
McMahon, C., Althof, S. E., Waldinger, M. D., Porst, H., Dean, J., Sharlip, I. D., & Buvat, J. (2008). An evidence‐based definition of lifelong premature ejaculation: Report of the International Society for Sexual Medicine (ISSM) Ad Hoc Committee for the definition of premature ejaculation. The Journal of Sexual Medicine, 5(7), 1590–1606.
McMahon, C., Jannini, E., Waldinger, M., & Rowland, D. (2013a). Standard operating procedures in the disorders of orgasm and ejaculation. The Journal of Sexual Medicine, 10(1), 204–229.
McMahon, C. G., Giuliano, F., Dean, J., Hellstrom, W. J., Bull, S., Tesfaye, F., … Aquilina, J. W. (2013b). Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: Randomized, placebo-controlled, phase III study. The Journal of Sexual Medicine, 10(9), 2312–2325.
Mitchell, K. R., Mercer, C. H., Ploubidis, G. B., Jones, K. G., Datta, J., Field, N., & Wellings, K. (2013). Sexual function in Britain: Findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). The Lancet, 382(9907), 1817–1829.
Patrick, D. L., Althof, S. E., Pryor, J. L., Rosen, R., Rowland, D. L., Ho, K. F., & Jamieson, C. (2005). Premature ejaculation: An observational study of men and their partners. The Journal of Sexual Medicine, 2(3), 358–367.
Porst, H. (2011). An overview of pharmacotherapy in premature ejaculation. The Journal of Sexual Medicine, 8(4), 335–341.
Porst, H. (2015). Premature ejaculation. In Y. Reisman, H. Porst, L. Lowenstein, F. Tripodi, & P. S. Kirana (Hrsg.), The ESSM manual of sexual medicine (2. Aufl.). Amsterdam: Medix.
Porst, H., & Cruz, N. (2015). Basic anatomy and physiology of ejaculation, classification of ejaculatory disorders. In Y. Reisman, H. Porst, L. Lowenstein, F. Tripodi, & P. S. Kirana (Hrsg.). The ESSM manual of sexual medicine (2nd updated edition 2015). Amsterdam: Medix Publishers.
Porst, H., Montorsi, F., Rosen, R. C., Gaynor, L., Grupe, S., & Alexander, J. (2007). The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: Prevalence, comorbidities, and professional help-seeking. European Urology, 51(3), 816–824.
Richardson, D., & Goldmeier, D. (2005). Premature ejaculation – Does country of origin tell us anything about etiology? The Journal of Sexual Medicine, 2(4), 508–512.
Rosen, R. C., & Althof, S. (2008). Impact of premature ejaculation: The psychological, quality of life, and sexual relationship consequences. The Journal of Sexual Medicine, 5(6), 1296–1307.
Rosen, R. C., McMahon, C. G., Niederberger, C., Broderick, G. A., Jamieson, C., & Gagnon, D. D. (2007). Correlates to the clinical diagnosis of premature ejaculation: Results from a large observational study of men and their partners. The Journal of Urology, 177(3), 1059–1064.
Rowland, D. L. (2006). Neurobiology of sexual response in men and women. CNS spectrums, 11(Suppl. 9), 6–12.
Rowland, D. L., Haensel, S. M., Blom, J. H., & Slob, A. K. (1993). Penile sensitivity in men with premature ejaculation and erectile dysfunction. Journal of Sex & Marital Therapy, 19(3), 189–197.
Rowland, D. L., Cooper, S. E., & Slob, A. K. (1998). The treatment of premature ejaculation: Psychological and biological strategies. Drugs of Today, 34, 879–899.
Rowland, D. L., Strassberg, D. S., De Gouveia Brazao, C. A., & Slob, A. K. (2000). Ejaculatory latency and control in men with premature ejaculation: An analysis across sexual activities using multiple sources of information. Journal of Psychosomatic Research, 48(1), 69–77.
Rowland, D. L., & Cooper, S. E. (2011). Practical tips for sexual counseling and psychotherapy in premature ejaculation. The Journal of Sexual Medicine, 8(Suppl. 4), 342–352.
Rowland, D. L., & Slob, A. K. (1997). Premature ejaculation: Psychophysiological considerations in theory, research, and treatment. Annual Review of Sex Research, 8(1), 224–253.
Rowland, D. L., Georgoff, V. L., & Burnett, A. L. (2011). Psychoaffective differences between sexually functional and dysfunctional men in response to a sexual experience. The Journal of Sexual Medicine, 8(1), 132–139.
Schapiro, B. (1943). Premature ejaculation: A review of 1,130 cases. Journal of Urology, 50, 374–379.
Semans, J. H. (1956). Premature ejaculation: A new approach. Southern Medical Journal, 49(4), 353–358.
Serefoglu, E. C., McMahon, C. G., Waldinger, M. D., Althof, S. E., Shindel, A., Adaikan, G., & Hellstrom, W. J. (2014). An evidence‐based unified definition of lifelong and acquired premature ejaculation: Report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. The Journal of Sexual Medicine, 11(6), 1423–1441.
Spiess, W. F., Geer, J. H., & O’Donohue, W. T. (1984). Premature ejaculation: Investigation of factors in ejaculatory latency. Journal of Abnormal Psychology, 93(2), 242–245.
Steggall, M. J., Fowler, C. G., & Pryce, A. (2008). Combination therapy for premature ejaculation: Results of a small-scale study. Sexual and Relationship Therapy, 23(4), 365–376.
Sunay, D., Sunay, M., Aydoğmuş, Y., Bağbancı, Ş., Arslan, H., Karabulut, A., & Emir, L. (2011). Acupuncture versus paroxetine for the treatment of premature ejaculation: A randomized, placebo-controlled clinical trial. European Urology, 59(5), 765–771.
Takeshita, J., & Litzinger, M. H. (2009). Serotonin syndrome associated with tramadol. Primary Care Companion to the Journal of Clinical Psychiatry, 11(5), 273.
Waldinger, M. D. (2002). The neurobiological approach to premature ejaculation. The Journal of Urology, 168(6), 2359–2367.
Waldinger, M. D. (2008a). Recent advances in the classification, neurobiology and treatment of premature ejaculation. In R. Balon (Hrsg.), Sexual Dysfunction. The Brain-Body Connection (Bd. 29, S. 50–69). Basel: Karger.
Waldinger, M. D. (2008b). Recent advances in the classification, neurobiologyand treatment of premature ejaculation. Advances in Psychosomatic Medicine, 29, 50–69.
Waldinger, M. D., & Schweitzer, D. H. (2008). The use of old and recent DSM definitions of premature ejaculation in observational studies: A contribution to the present debate for a new classification of PE in the DSM-V. The Journal of Sexual Medicine, 5, 1079–1087.
Waldinger, M. D., Hengeveld, M. W., & Zwinderman, A. H. (1994). Paroxetine treatment of premature ejaculation: A double-blind, randomized, placebo-controlled study. American Journal of Psychiatry, 151(9), 1377–1379.
Waldinger, M. D., Hengeveld, M. W., Zwinderman, A. H., & Olivier, B. (1998a). Effect of SSRI antidepressants on ejaculation: A double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. Journal of Clinical Psychopharmacology, 18(4), 274–281.
Waldinger, M. D., Rietschel, M., Nothen, N., Hengeveld, M. W., & Olivier, B. (1998b). Familial occurrence of primary premature ejaculation. Psychiatric Genetics, 8, 37–40.
Waldinger, M. D., Zwinderman, A., Schweitzer, D., & Olivier, B. (2004). Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. International Journal of Impotence Research, 16(4), 369–381.
Waldinger, M. D., Quinn, P., Dilleen, M., Mundayat, R., Schweitzer, D. H., & Boolell, M. (2005a). Ejaculation disorders: A multinational population survey of intravaginal ejaculation latency time. The Journal of Sexual Medicine, 2, 492–497.
Waldinger, M. D., Zwinderman, A. H., Olivier, B., & Schweitzer, D. H. (2005b). Proposal for a definition of lifelong premature ejaculation based on epidemiological stopwatch data. The Journal of Sexual Medicine, 2(4), 498–507.
Waldinger, M. D., McIntosh, J., & Schweitzer, D. H. (2009). A five‐nation survey to assess the distribution of the intravaginal ejaculatory latency time among the general male population. The Journal of Sexual Medicine, 6(10), 2888–2895.
Xia, J., Han, Y., Zhou, L., Xu, Z., Chen, Y., & Dai, Y. (2014). Sympathetic skin response in patients with primary premature ejaculation. International Journal of Impotence Research, 26(1), 31–34.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Germany
About this chapter
Cite this chapter
Neuhof, C., Hartmann, U. (2018). Vorzeitige (frühe) Ejakulation. In: Hartmann, U. (eds) Sexualtherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54415-0_14
Download citation
DOI: https://doi.org/10.1007/978-3-662-54415-0_14
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-54414-3
Online ISBN: 978-3-662-54415-0
eBook Packages: Psychology (German Language)